| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |